» Articles » PMID: 31001485

Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition

Overview
Date 2019 Apr 20
PMID 31001485
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

Antimicrobial resistance constitutes one of the major challenges facing humanity in the Twenty-First century. The spread of resistant pathogens has been such that the possibility of returning to a pre-antibiotic era is real. In this scenario, innovative therapeutic strategies must be employed to restrict resistance. Among the innovative proposed strategies, anti-virulence therapy has been envisioned as a promising alternative for effective control of the emergence and spread of resistant pathogens. This review presents some of the anti-virulence strategies that are currently being developed, it will cover strategies focused on quench pathogen quorum sensing (QS) systems, disassemble of bacterial functional membrane microdomains (FMMs), disruption of biofilm formation and bacterial toxin neutralization.

Citing Articles

Comprehensive analysis of antimicrobial resistance, biofilm formation and virulence factors of staphylococci isolated from bovine mastitis.

Moreno J, Diana L, Martinez M, Iribarnegaray V, Puentes R Heliyon. 2025; 11(4):e42749.

PMID: 40066049 PMC: 11891686. DOI: 10.1016/j.heliyon.2025.e42749.


Potent human antibodies against SpA5 identified by high-throughput single-cell sequencing of phase I clinical volunteers' B cells.

Wang W, Li X, Ou Y, Zhou J, Gu Y, Liu B iScience. 2025; 28(1):111627.

PMID: 39834865 PMC: 11743104. DOI: 10.1016/j.isci.2024.111627.


Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research.

Sussmuth R, Sussmuth R, Kulike-Koczula M, Kulike-Koczula M, Gao P, Kosol S Angew Chem Int Ed Engl. 2024; 64(10):e202414325.

PMID: 39611429 PMC: 11878372. DOI: 10.1002/anie.202414325.


A peptide targeting outer membrane protein A of exhibits antibacterial activity by reducing bacterial pathogenicity.

Zhao H, Hu Y, Nie D, Li N, Chen Z, Zhou S Antimicrob Agents Chemother. 2024; 68(12):e0056524.

PMID: 39503487 PMC: 11619439. DOI: 10.1128/aac.00565-24.


Bloodstream infections: mechanisms of pathogenesis and opportunities for intervention.

Holmes C, Albin O, Mobley H, Bachman M Nat Rev Microbiol. 2024; .

PMID: 39420097 DOI: 10.1038/s41579-024-01105-2.


References
1.
Abbas H, Elsherbini A, Shaldam M . Repurposing metformin as a quorum sensing inhibitor in . Afr Health Sci. 2017; 17(3):808-819. PMC: 5656202. DOI: 10.4314/ahs.v17i3.24. View

2.
Goh W, Gardner C, Chandra Sekhar K, Biswas N, Nizalapur S, Rice S . Synthesis, quorum sensing inhibition and docking studies of 1,5-dihydropyrrol-2-ones. Bioorg Med Chem. 2015; 23(23):7366-77. DOI: 10.1016/j.bmc.2015.10.025. View

3.
Pan W, Fan M, Wu H, Melander C, Liu C . A new small molecule inhibits Streptococcus mutans biofilms in vitro and in vivo. J Appl Microbiol. 2015; 119(5):1403-11. PMC: 4633698. DOI: 10.1111/jam.12940. View

4.
Citorik R, Mimee M, Lu T . Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol. 2014; 32(11):1141-5. PMC: 4237163. DOI: 10.1038/nbt.3011. View

5.
Yadav M, Go Y, Chae S, Song J . The Small Molecule DAM Inhibitor, Pyrimidinedione, Disrupts Streptococcus pneumoniae Biofilm Growth In Vitro. PLoS One. 2015; 10(10):e0139238. PMC: 4592238. DOI: 10.1371/journal.pone.0139238. View